Results 31 to 40 of about 8,266,387 (310)
Brain tumors induced in rats by human adenovirus type 12 [PDF]
, 1974 Oncogenesis of human adenovirus type 12 in the brain of rats was examined. Newborn rats of Sprague-Dawley and Donryu strains were injected intracranially with human adenovirus type 12. The incidence of intracranial tumors was 91% (30/33) in
Ogawa, Katsuo +5 more
core +1 more source
Detecting liquid remnants of solid tumors: circulating tumor DNA minimal residual disease
Cancer Discovery, 2021 Growing evidence demonstrates that circulating tumor DNA (ctDNA) minimal residual disease (MRD) following treatment for solid tumors predicts relapse.
E. Moding +3 more
semanticscholar +1 more source
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Journal of Nuclear Medicine, 2009 The purpose of this article is to review the status and limitations of anatomic tumor response metrics including the World Health Organization (WHO) criteria, the Response Evaluation Criteria in Solid Tumors (RECIST), and RECIST 1.1.
R. Wahl, H. Jacene, Y. Kasamon, M. Lodge
semanticscholar +1 more source
Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
Frontiers in Immunology, 2022 Tumor-infiltrating lymphocytes (TILs), frontline soldiers of the adaptive immune system, are recruited into the tumor site to fight against tumors. However, their small number and reduced activity limit their ability to overcome the tumor. Enhancement of
M. Kazemi +6 more
semanticscholar +1 more source
Management of germ cell tumors in children: Approaches to cure [PDF]
, 2002 The introduction of cisplatinum chemotherapy and current advances in the surgical treatment have resulted in a dramatic improvement of the prognosis of children with malignant germ cell tumors (GCT).
Schneider, D. T. +9 more
core +1 more source
CAR-macrophage: A new immunotherapy candidate against solid tumors.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021 Chimeric antigen receptor (CAR)-T cell therapy has been shown to be an effective treatment for hematological tumors, but the treatment of solid tumors still lacks effectiveness.
Yi-Zhao Chen +9 more
semanticscholar +1 more source
, 2023 Benign solid liver tumors are frequently discovered during routine sonographic examinations. As a rule, malignant tumors can be excluded using contrast medium-based sectional imaging; however, unclear cases can represent a diagnostic challenge.
Neumann, U.P. +3 more
core +1 more source
Antitumor activity of the tea polyphenol epigallocatechin-3-gallate encapsulated in targeted vesicles after intravenous administration [PDF]
, 2013 The therapeutic potential of epigallocatechin gallate, a green tea polyphenol with anti-cancer properties, is limited by its inability to specifically reach tumors following intravenous administration.
Dufès, Christine +7 more
core +4 more sources
Nature Communications, 2023 Drug combinations are key to circumvent resistance mechanisms compromising response to single anti-cancer targeted therapies. The implementation of combinatorial approaches involving MEK1/2 or KRASG12C inhibitors in the context of KRAS-mutated lung ...
Irati Macaya +31 more
doaj +1 more source
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
Frontiers in Immunology, 2021 Cellular immunotherapies represent a promising approach for the treatment of cancer. Engineered adoptive cell therapies redirect and augment a leukocyte’s inherent ability to mount an immune response by introducing novel anti-tumor capabilities and ...
Chris Sloas, Saar I. Gill, M. Klichinsky
semanticscholar +1 more source